Literature DB >> 26716497

Relative Risks of Thrombosis and Bleeding in Different ABO Blood Groups.

Massimo Franchini1, Giuseppe Lippi2.   

Abstract

The ABO blood group system is composed of complex carbohydrate molecules (i.e., the A, B, and H determinants) that are widely expressed on the surface of red blood cells and in a variety of other cell and tissues. Along with their pivotal role in transfusion and transplantation medicine, the ABO antigens participate in many other physiological processes and, in particular, are important determinants of von Willebrand factor and factor VIII circulating plasma levels. The precise influence of the ABO system on hemostasis has led the way to the investigation of a putative implication in the risk of developing cardiovascular disorders. Along with the underlying molecular mechanisms, the current knowledge on the role of ABO blood group antigens in both the thrombotic and hemorrhagic risk will be summarized in this narrative review. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26716497     DOI: 10.1055/s-0035-1564832

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  15 in total

1.  Influence of ABO blood group on sports performance.

Authors:  Giuseppe Lippi; Giorgio Gandini; Gian Luca Salvagno; Spyros Skafidas; Luca Festa; Elisa Danese; Martina Montagnana; Fabian Sanchis-Gomar; Cantor Tarperi; Federico Schena
Journal:  Ann Transl Med       Date:  2017-06

2.  Acute coronary syndrome: many doubts, some answers.

Authors:  Giuseppe Lippi; Gianfranco Cervellin
Journal:  Ann Transl Med       Date:  2016-05

3.  O blood type is a risk factor for upper gastrointestinal bleeding.

Authors:  Massimo Franchini; Thomas Togliani; Rosalia Turdo; Giuseppe Lucchini; Carlo Bonfanti; Ivano Giacomini; Mario Luppi; Stefano Pilati
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

4.  Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion.

Authors:  Nareg H Roubinian; Colleen Plimier; Jennifer P Woo; Catherine Lee; Roberta Bruhn; Vincent X Liu; Gabriel J Escobar; Steven H Kleinman; Darrell J Triulzi; Edward L Murphy; Michael P Busch
Journal:  Blood       Date:  2019-07-26       Impact factor: 22.113

Review 5.  Red blood cells: the forgotten player in hemostasis and thrombosis.

Authors:  J W Weisel; R I Litvinov
Journal:  J Thromb Haemost       Date:  2019-01-07       Impact factor: 5.824

6.  ABO blood group in aneurysmal subarachnoid haemorrhage-a pilot study.

Authors:  Oliver Richards; Kirsten J Cromie; Christopher Akhunbay-Fudge; Neeraj Kalra; Richard G Feltbower; Paul Chumas; Ian A Anderson
Journal:  Acta Neurochir (Wien)       Date:  2022-01-18       Impact factor: 2.216

7.  The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program.

Authors:  Enrico Capuzzo; Carlo Bonfanti; Francesco Frattini; Paolo Montorsi; Rosalia Turdo; Maria Grazia Previdi; Elisa Turrini; Massimo Franchini
Journal:  Ann Transl Med       Date:  2016-05

8.  Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method.

Authors:  Phillip A Coghill; Suren Kanchi; Zheila J Azartash-Namin; James W Long; Trevor A Snyder
Journal:  ASAIO J       Date:  2019-07       Impact factor: 2.872

9.  Genome-wide analysis of 944 133 individuals provides insights into the etiology of haemorrhoidal disease.

Authors:  Tenghao Zheng; David Ellinghaus; Simonas Juzenas; Clemens Schafmayer; Mauro D'Amato; Andre Franke; François Cossais; Greta Burmeister; Gabriele Mayr; Isabella Friis Jørgensen; Maris Teder-Laving; Anne Heidi Skogholt; Sisi Chen; Peter R Strege; Go Ito; Karina Banasik; Thomas Becker; Frank Bokelmann; Søren Brunak; Stephan Buch; Hartmut Clausnitzer; Christian Datz; Frauke Degenhardt; Marek Doniec; Christian Erikstrup; Tõnu Esko; Michael Forster; Norbert Frey; Lars G Fritsche; Maiken Elvestad Gabrielsen; Tobias Gräßle; Andrea Gsur; Justus Gross; Jochen Hampe; Alexander Hendricks; Sebastian Hinz; Kristian Hveem; Johannes Jongen; Ralf Junker; Tom Hemming Karlsen; Georg Hemmrich-Stanisak; Wolfgang Kruis; Juozas Kupcinskas; Tilman Laubert; Philip C Rosenstiel; Christoph Röcken; Matthias Laudes; Fabian H Leendertz; Wolfgang Lieb; Verena Limperger; Nikolaos Margetis; Kerstin Mätz-Rensing; Christopher Georg Németh; Eivind Ness-Jensen; Ulrike Nowak-Göttl; Anita Pandit; Ole Birger Pedersen; Hans Günter Peleikis; Kenneth Peuker; Cristina Leal Rodriguez; Malte Christoph Rühlemann; Bodo Schniewind; Martin Schulzky; Jurgita Skieceviciene; Jürgen Tepel; Laurent Thomas; Florian Uellendahl-Werth; Henrik Ullum; Ilka Vogel; Henry Volzke; Lorenzo von Fersen; Witigo von Schönfels; Brett Vanderwerff; Julia Wilking; Michael Wittig; Sebastian Zeissig; Myrko Zobel; Matthew Zawistowski; Vladimir Vacic; Olga Sazonova; Elizabeth S Noblin; Gianrico Farrugia; Arthur Beyder; Thilo Wedel; Volker Kahlke
Journal:  Gut       Date:  2021-04-22       Impact factor: 23.059

10.  ABO blood groups do not predict progression of traumatic intracranial hemorrhage.

Authors:  Alyssa M Tutunjian; Sandra S Arabian; Jacqueline Paolino; Elizabeth S Wolfe; Eric J Mahoney; Horacio M Hojman; Benjamin P Johnson; Nikolay Bugaev
Journal:  J Clin Neurosci       Date:  2021-06-23       Impact factor: 2.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.